1999 Grants

• Additional 1998-1999 Pilot Study Grants

• Delivery of L-dopa and GDNF in Animal Models of Parkinson’s Disease Via Recombinant Adeo-Associated Virus Mediated Gene

• Assessing A2a Adenosine Antagonists as a Novel Anti-parkinsonian Agent Using a A2a Receptor Knock-out Model

• Physiologic Effects of Deep Brain Stimulation in Patients with Parkinson’s Disease

• Mechanisms of MPTP-Induced DNA Damage: Studies in Genetically Engineered Mice

• The Role of JNK3 Signaling Pathway in Neural Death: Practical Implication for the Study of Excitatory Phenomenon Neurodegenerative Disease with Special Reference to Parkinson’s Disease

• Glutamatergic Compensation After MPTP Lesioning in Mice

• Dopamine Neural Survival in Mice Lacking Glutathione Peroxides

• Role of Survival of Motor Neuron Protein Apoptosis of Parkinson’s Disease

• Tryosine Hydroxylase as a Cytotoxic Protein in Parkinson’s Disease

• Nurrl Gene and Parkinson’s Disease

• Magnetic Resonance Spectroscopy and Brain Energy Metabolism in Parkinson’s Disease

• Is There a Difference in Nigral Dopaminergic Neural Numbers Amongst Normal Individuals of Different Racial Origins?

• The Functional Organization of the Primate Pallidum: Targets for Gene Based Therapy for Parkinson’s Disease

• Gene Therapy in Rat Model of Parkinson’s Disease

• Characterization of the Role of Dopamine in the Primate Substania Nigra